OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE

2035 reported adverse events

These side effects are most commonly reported by patients taking OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE:

# Side effect Count
0 DEVICE DELIVERY SYSTEM ISSUE 705
1 PRODUCT USE IN UNAPPROVED INDICATION 612
2 DRUG DOSE OMISSION BY DEVICE 520
3 PRODUCT USE ISSUE 431
4 DRUG INEFFECTIVE 198
5 DEVICE ISSUE 160
6 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 144
7 DEVICE OCCLUSION 134
8 EPISTAXIS 125
9 CONDITION AGGRAVATED 73
See all common reactions for OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE

OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRODUCT TAMPERING 71 0.0395
1 DEVICE DELIVERY SYSTEM ISSUE 705 0.0257
2 PRODUCT CLOSURE ISSUE 8 0.0144
3 PRODUCT AFTER TASTE 13 0.0136
4 PLEUROPERICARDITIS 5 0.0121
5 DEVICE OCCLUSION 134 0.0095
6 PRODUCT DELIVERY MECHANISM ISSUE 46 0.0085
7 PRODUCT DEPOSIT 11 0.0071
8 DRUG DOSE OMISSION BY DEVICE 520 0.0066
9 PRODUCT CONTAINER SEAL ISSUE 11 0.0063
See all enriched reactions for OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE